IL18 and neoplasm: All mice implanted with RM1-IL18 tumor cells orthotopically (in the prostate) developed tumors (Fig. 1 D), however, neutralization of IL-18 through αIL-18 treatment resulted in significantly larger tumors (p<0.001).